Replimune Group, Inc. (REPL)
7.02
+0.01
(+0.14%)
USD |
NASDAQ |
Jan 21, 09:51
Replimune Group Price: 7.02 for Jan. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Rapt Therapeutics, Inc. | 57.61 |
| Olema Pharmaceuticals, Inc. | 26.72 |
| CorMedix, Inc. | 6.86 |
| Verastem, Inc. | 6.61 |
| Anavex Life Sciences Corp. | 5.00 |
Price Related Metrics
| PEG Ratio | -0.1235 |
| Price to Book Value | 2.091 |
| Earnings Yield | -51.39% |
| Market Cap | 550.67M |
| PEGY Ratio | -0.1235 |